224 related articles for article (PubMed ID: 25595423)
1. Modeling falls in Parkinson's disease: Slow gait, freezing episodes and falls in rats with extensive striatal dopamine loss.
Kucinski A; Albin RL; Lustig C; Sarter M
Behav Brain Res; 2015 Apr; 282():155-64. PubMed ID: 25595423
[TBL] [Abstract][Full Text] [Related]
2. Complex Movement Control in a Rat Model of Parkinsonian Falls: Bidirectional Control by Striatal Cholinergic Interneurons.
Avila C; Kucinski A; Sarter M
J Neurosci; 2020 Jul; 40(31):6049-6067. PubMed ID: 32554512
[TBL] [Abstract][Full Text] [Related]
3. Modeling Parkinson's disease falls associated with brainstem cholinergic systems decline.
Kucinski A; Sarter M
Behav Neurosci; 2015 Apr; 129(2):96-104. PubMed ID: 25798629
[TBL] [Abstract][Full Text] [Related]
4. Reducing falls in Parkinson's disease: interactions between donepezil and the 5-HT
Kucinski A; de Jong IE; Sarter M
Eur J Neurosci; 2017 Jan; 45(2):217-231. PubMed ID: 27469080
[TBL] [Abstract][Full Text] [Related]
5. Co-treatment with rivastigmine and idalopirdine reduces the propensity for falls in a rat model of falls in Parkinson's disease.
Koshy Cherian A; Kucinski A; Wu R; de Jong IEM; Sarter M
Psychopharmacology (Berl); 2019 Jun; 236(6):1701-1715. PubMed ID: 30607479
[TBL] [Abstract][Full Text] [Related]
6. Reduction of falls in a rat model of PD falls by the M1 PAM TAK-071.
Kucinski A; Sarter M
Psychopharmacology (Berl); 2021 Jul; 238(7):1953-1964. PubMed ID: 33735392
[TBL] [Abstract][Full Text] [Related]
7. Where attention falls: Increased risk of falls from the converging impact of cortical cholinergic and midbrain dopamine loss on striatal function.
Sarter M; Albin RL; Kucinski A; Lustig C
Exp Neurol; 2014 Jul; 257():120-9. PubMed ID: 24805070
[TBL] [Abstract][Full Text] [Related]
8. Modeling fall propensity in Parkinson's disease: deficits in the attentional control of complex movements in rats with cortical-cholinergic and striatal-dopaminergic deafferentation.
Kucinski A; Paolone G; Bradshaw M; Albin RL; Sarter M
J Neurosci; 2013 Oct; 33(42):16522-39. PubMed ID: 24133257
[TBL] [Abstract][Full Text] [Related]
9. Make a Left Turn: Cortico-Striatal Circuitry Mediating the Attentional Control of Complex Movements.
Sarter M; Avila C; Kucinski A; Donovan E
Mov Disord; 2021 Mar; 36(3):535-546. PubMed ID: 33615556
[TBL] [Abstract][Full Text] [Related]
10. Dopamine depletion impairs gait automaticity by altering cortico-striatal and cerebellar processing in Parkinson's disease.
Gilat M; Bell PT; Ehgoetz Martens KA; Georgiades MJ; Hall JM; Walton CC; Lewis SJG; Shine JM
Neuroimage; 2017 May; 152():207-220. PubMed ID: 28263926
[TBL] [Abstract][Full Text] [Related]
11. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
Huot P; Lévesque M; Parent A
Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
[TBL] [Abstract][Full Text] [Related]
12. Cholinergic system correlates of postural control changes in Parkinson's disease freezers.
Roytman S; Paalanen R; Griggs A; David S; Pongmala C; Koeppe RA; Scott PJH; Marusic U; Kanel P; Bohnen NI
Brain; 2023 Aug; 146(8):3243-3257. PubMed ID: 37086478
[TBL] [Abstract][Full Text] [Related]
13. Contributions of signaling by dopamine neurons in dorsal striatum to cognitive behaviors corresponding to those observed in Parkinson's disease.
Darvas M; Henschen CW; Palmiter RD
Neurobiol Dis; 2014 May; 65():112-23. PubMed ID: 24491966
[TBL] [Abstract][Full Text] [Related]
14. Serotonin and dopamine striatal innervation in Parkinson's disease and Huntington's chorea.
Bédard C; Wallman MJ; Pourcher E; Gould PV; Parent A; Parent M
Parkinsonism Relat Disord; 2011 Sep; 17(8):593-8. PubMed ID: 21664855
[TBL] [Abstract][Full Text] [Related]
15. Partial dopaminergic denervation-induced impairment in stimulus discrimination acquisition in parkinsonian rats: a model for early Parkinson's disease.
Eagle AL; Olumolade OO; Otani H
Neurosci Res; 2015 Mar; 92():71-9. PubMed ID: 25452126
[TBL] [Abstract][Full Text] [Related]
16. L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia.
Lindgren HS; Andersson DR; Lagerkvist S; Nissbrandt H; Cenci MA
J Neurochem; 2010 Mar; 112(6):1465-76. PubMed ID: 20050978
[TBL] [Abstract][Full Text] [Related]
17. The degeneration of dopaminergic synapses in Parkinson's disease: A selective animal model.
Morales I; Sanchez A; Rodriguez-Sabate C; Rodriguez M
Behav Brain Res; 2015 Aug; 289():19-28. PubMed ID: 25907749
[TBL] [Abstract][Full Text] [Related]
18. Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease.
Yuan H; Sarre S; Ebinger G; Michotte Y
J Neurosci Methods; 2005 May; 144(1):35-45. PubMed ID: 15848237
[TBL] [Abstract][Full Text] [Related]
19. Dopaminergic and non-dopaminergic pharmacological hypotheses for gait disorders in Parkinson's disease.
Devos D; Defebvre L; Bordet R
Fundam Clin Pharmacol; 2010 Aug; 24(4):407-21. PubMed ID: 20163480
[TBL] [Abstract][Full Text] [Related]
20. Role of pedunculopontine cholinergic neurons in the vulnerability of nigral dopaminergic neurons in Parkinson's disease.
Bensaid M; Michel PP; Clark SD; Hirsch EC; François C
Exp Neurol; 2016 Jan; 275 Pt 1():209-19. PubMed ID: 26571193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
